OBEZİTEDE NÖRODEJENERASYON
Özet
Obezite, sinir sisteminde yapısal ve fonksiyonel nöron kayıplarına (nörodejenerasyon) yol açarak Alzheimer, Parkinson ve Huntington gibi nörodejeneratif hastalıklar ile demans riskini artıran kronik bir metabolik bozukluktur. Obezitenin beyindeki yıkıcı etkileri; artan reaktif oksijen türlerinin (ROS) antioksidan kapasiteyi aşmasıyla oluşan oksidatif stres, mikrogliya ve astrosit aktivasyonu ile seyreden nöroinflamasyon, endoplazmik retikulum (ER) stresi, kan-beyin bariyeri geçirgenliğindeki bozulmalar ile insülin, IGF-1 ve leptin direnci gibi hücresel mekanizmalar üzerinden gerçekleşmektedir. Artan adipoz doku kaynaklı pro-inflamatuar sitokinler (TNF-α, IL-6) ve seramidler, merkezi sinir sistemine ulaşarak nöroprotektif etkileri engellemekte ve apoptozisi tetiklemektedir. Obeziteye bağlı gelişen insülin direnci hipokampal nöronal kayba yol açarak bilişsel işlevleri zayıflatmakta ve Alzheimer hastalığının Tip 3 Diyabet (T3DM) olarak tanımlanmasına zemin hazırlamaktadır. Benzer şekilde, obezitede gelişen leptin direnci de nöronal hayatta kalma sinyallerini bozmaktadır. Tüm bu yolaklar birbirini tetikleyen bir kaskad halinde çalışarak hipokampus ve hipotalamusta atrofiye ve hafıza kayıplarına yol açmaktadır.
Referanslar
Elmas Ç, Seymen CM. (2019). Through the Perspective of Histology - The Alzheimer’s Disease Promotion by Obesity and Glucose Metabolism: Type 3 Diabetes. Atta-ur-Rahman (Ed.), Frontiers in Clinical Drug Research (Diabetes and Obesity) Volume 4 içinde (s.135-177). Bentham e-Books.
Miller AA, Spencer SJ. Obesity and neuroinflammation: A pathway to cognitive impairment. Brain, Behavior, and Immunity, 2014; 42:10–21. doi: 10.1016/j.bbi.2014.04.001.
Lepara O. (2020). Interplay between oxidative stress and meta-inflammation in obesity-related neurodegeneration. Asija Zaciragic (Ed.), Meta-Inflammation and Obesity içinde (s.152-177). Bentham Books.
Mazon JN, Mello AH, Ferreira HK, et al. The impact of obesity on neurodegenerative diseases. Life Sciences, 2017; 182:22-28. doi: 10.1016/j.lfs.2017.06.002.
Cai D. Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Cell Press, 2013; 24(1):40-46. doi: 10.1016/j.tem.2012.11.003.
Ravanan P, Awada R, Harry GJ, et al. (2010). White fat tissue, obesity, and possible role in neurodegeneration. G. Jean Harry, Hugh A. Tilson (Ed.), Neurotoxicology içinde (s.156-174). Informa Healthcare.
Salim S. Oxidative stress and the central nervous system. Journal of Pharmacology and Experimental Therapeutics, 2017; 380:201-205. doi: 10.1124/jpet.116.237503.
Büyükuslu N, Yiğitbaşı T. Reaktif oksijen türleri ve obezitede oksidatif stres. MÜSBED, 2015; 5(3):197-203. doi: 10.5455/musbed.20150604061607.
Trifunovic A, Wredenberg A, Falkenberg M, et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature, 2004; 429:417–423. doi: 10.1038/nature02517.
Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. Journal of Clinical Investigation, 2004; 114(12):1752-1761. doi: 10.1172/JCI21625.
Gupta R, Sawhney P, Ambasta R, et al. Obesity and neurodegeneration. Advances in Obesity, Weight Management & Control, 2015; 2(5):96-101.
Rigotto G, Basso E. Mitochondrial dysfunctions: A thread sewing together Alzheimer’s disease, diabetes, and obesity. Oxidative Medicine and Cellular Longevity, 2019; 2019:1-16. doi: 10.1155/2019/7210892.
Liu Z, Zhou T, Ziegler AC, et al. Oxidative stress in neurodenerative diseases: From molecular mechanisms to clinical applications. Oxidative Medicine and Cellular Longevity, 2017; 2017:1-11. doi: 10.1155/2017/2525967.
Dias V, Juhn E, Mouradian MM. The role of oxidative stress in Parkinson’s disease. Journal of Parkinson’s Disease, 2013; 3(4): 461-491. doi: 10.3233/JPD-130230.
Avignon A, Hokayem, Bisbal C, et al. Dietary antioxidants: Do they have a role to play in the on going fight against abnormal glucose metabolism? Nutrition, 2012; 28(7-8):715-721. doi: 10.1016/j.nut.2012.01.001.
Spielman LJ, Little JP, Klegeris A. Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration. Journal of Neuroimmunology, 2014; 273:8-21. doi: 10.1016/j.jneuroim.2014.06.004.
Swardfager W, Lanctôt K, Rothenburg L, et al. A meta-analysis of cytokines in Alzheimer’s disease. Biological Psychiatry, 2010; 68(10):930-41. doi: 10.1016/j.biopsych.2010.06.012.
Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes & Metabolism, 2004; 30(1): 13. doi: 10.1016/S1262-3636(07)70084-8.
Wang C, Ha X, Li W, et al. Correlation of TLR4 and KLF7 in inflammation induced by obesity. Inflammation, 2017; 40(1): 42-51. doi: 10.1007/s10753-016-0450-z.
Trotta T, Porro C, Calvello R, et al. Biological role of Toll-like receptor-4 in the brain. Journal of Neuroimmunology, 2014; 268(1-2):1-12. doi: 10.1016/j.jneuroim.2014.01.014.
Martin-Jimenez CA, Garcia-Vega A, Cabezas R, et al. Astrocytes and endoplasmic reticulum stress: A bridge between obesity and neurodegenerative diseases. Progress in Neurobiology, 2017; 158:45-68. doi: 10.1016/j.pneurobio.2017.08.001.
Sweeney P, Park H, Baumann M, et al. Protein misfolding in neurodegenerative diseases: Implications and strategies. Translational Neurodegeneration, 2017; 6(1):6. doi: 10.1186/s40035-017-0077-5.
Barreto GE. Targeting astrocytes in brain injuries: a translational research approach. Progress in Neurobiology, 2016; 144:1–4. doi: 10.1016/j.pneurobio.2016.09.001.
Chaudhari N, Talwar P, Parimisetty A, et al. A molecular web: endoplasmic reticulum stress, inflammation, and oxidative stress. Frontiers in Cellular Neuroscience, 2014; 8:213. doi: 10.3389/fncel.2014.00213.
Biessels GJ, Ter Laak MP, Hamers FPT, et al. Neuronal Ca2+ disregulation in diabetes mellitus. European Journal of Pharmacology, 2002; 447(2-3):201-9. doi:10.1016/S0014-2999(02)01844-7.
Rapoport SI. In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling. Journal of Molecular Neuroscience, 2001; 16(2–3):243-261. doi: 10.1385/JMN:16:2-3:243.
Buckman LB, Thompson MM, Lippert RN, et al. Evidence for a novel functional role of astrocytes in the acute homeostatic response to high-fat diet intake in mice. Molecular Metabolism, 2015; 4(1):58–63. doi: 10.1016/j.molmet.2014.10.001.
Pellecchia MT, Santangelo G, Picillo M, et al. Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naive Parkinson's disease. European Journal of Neurology, 2014; 21:802–807. doi: 10.1111/ene.12137.
Grilli M, Ferrari Toninelli G, Uberti D, et al. Alzheimer’s disease linking neurodegeneration with neurodevelopment. Functional Neurology, 2003; 18(3):145-148.
Mittal K, Katare DP. Shared links between type 2 diabetes mellitus and Alzheimer’s disease: A review. Diabetology & Metabolic Syndrome, 2016; 10(2):144-149. doi:10.1016/j.dsx.2016.01.021.
Rivera EJ, Goldin A, Fulmer N, et al. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer’s disease: Link to brain reductions in acetylcholine. Journal of Alzheimer’s Disease, 2005; 8(3):247-68. doi: 10.3233/JAD-2005-8304.
Doherty GH. Obesity and the ageing brain: Could leptin play a role in neurodegeneration? Current Gerontology and Geriatrics Research, 2011; 2011:708154. doi: 10.1155/2011/708154.
Lee EB. Obesity, leptin, and Alzheimer's disease. Annals of the New York Academy of Sciences, 2011; 1243:15-29. doi: 10.1111/j.1749-6632.2011.06274.x.
Hekimoğlu A. Leptin direnci ve obezite. ARŞİV, 2007; 16:50.
Doherty GH, Oldreive C, Harvey J. Neuroprotective actions of leptin on central and peripheral neurons in vitro. Neuroscience, 2008; 154(4):1297–1307. doi: 10.1016/j.neuroscience.2008.04.052.
Dicou E, Attoub S, Gressens P. Neuroprotective effects of leptin in vivo and in vitro. NeuroReport, 2001; 12(18):3947–3951. doi: 10.1097/00001756-200112210-00019.